Ciprofloxacin is a broad-spectrum synthetic quinolone antibacterial agent. h is active
against most of the gram-negative aerobic barteria like Enterobacteriaceas & Pseudomonas aeruginosa and gram
positive aerobic bacteria including penicillinase producing, penicillinase
non-producing and Methicillin-resistant Staphylococci.
The bactericidal action of Ciprofloxacin results from interfering with
the enzyme DNA gyrase.
Indications
Ciprofloxacin
is indicated for the management of single or mixed infections caused by two or
more susceptible mirooraganisms. It can also be used against infections caused
by organisms resistant to other antibiotics. Ciprofloxacin is indicated for the
treatment of the following infections.
Gastrointestinal
tract infection: Typhoid fever and infected diarrhoea. Urinary tract infection:
Complicated
and uncomplicated urethritis, cystitis, pyelonephritis, prostatitis and
epididymitis.
Respiratory
tract infection: Pneumonia, acute and chronic bronchitis, cystic fibrosis,
bronchiectasis and empyema. Skin and soft tissue infection: Wound infection,
abscess, infected ulcer, cellulitis, infected burn, erysipelas and otitis
externa. Severe systemic infection: Septicemia, bacteremia, infection in immunosuppressive
patient with hematological or solid tumors. Biliary tract infection:
Cholangitis, cholecystitis, empyema of the gall bladder. Eye, ear, nose and
throat infection: Otitis media, sinusitis, mastoiditis and tonsillitis. Bone
and joint infection: Osteomylitis and arthritis. Pelvic infection: Salpingitis,
endometritis and pelvic inflammatory diseases. Abdominal infection: Peritonitis
& infra-abdominal abscess. Gonorrhea: Urethral, rectal and pharyngeal gonorrhea caused by beta-lactate producing
organisms
or organisms moderately sensitive to penicillin.
Dosage
and administration
Adult:
The usual adult dose is 250-750 mg 12 hourly. Usual dosage schedule Typhoid Fever: 500 mg 12 hourly 7-14 days
Infected Diarrhea: 500 mg 12 hourly 5-7 days
Chronic Salmonella Carriers: 500-750
mg 12 hourly 28 days Complicated UTI:
500
mg 12 hourly 3-5 days
Uncomplicated UTI: 250 mg 12 hourly 3-5 days
Respiratory Tract Infection: 500-750
mg 12 hourly 7-14 days Skin and Soft Tissue Infection: 500-750 mg
12
hourly 7-14 days Uncomplicated Gonorrhea: 250
mg single dose
Uncomplicated Gonorrhea: 250 mg single dose
Wound Infection: 500 mg 12 hourly 7-14 days
Bone and Joint Infection: 500-750 mg 12 hourly 7-14
days
Other
Infection: 500.750
mg 12 hourly 7-14 days
Adolescent
and Children: Generally not recommended but where the benefit is more than
potential risk, the dose should be 10-30 mg/kg/day depending upon the severity
of Infection, administered in two divided doses.
Side
effects
Ciprofloxacin
is generally well tolerated. Gastrointestinal disturbances like nausea,
vomiting, diarrhea, dyspepsia and abdominal pain; CNS disturbances e.g.
dizziness, drowsiness, headache, tiredness, confusion. convulsion, skin rashes, prurient and possible systemic reactions may occur. It has also been reported that
joint pain, mild photo sensitivity may occur and liver enzyme, serum bilirubin, creation levels may increase slightly
after
administration.
Precautions
Ciprofloxacin
should be used with great caution it patient with a known history of epilepsy
or other factors, which predispose to seizure and convulsion. Patients should
be advised to take Clprofloxacin two hours after meal. Patients should be
advised not to take Antacid containing aluminum or magnesium concomitantly or within
two hours after dosing and also requested to drink plenty of water.
Pregnancy
and lactation
Ciprofloxacin
has been shown to cause arthropathy it immature annals and therefore its use
during pregnancy is not yet recommended. It has been reported that
Ciprofloxacin is secreted in milk during administration to nursing mother and
is thus not also recommended yet.
Drug
interactions
Concurrent
administration of Ciprofloxacin with Theophyline and Caffeine may potentiate
the adverse effects of theophyline and caffeine. Antacid containing aluminum
or magnesium may decrease the bioavailablllty of Clprofloxacin. Quinolones,
including Ciprofloxacin, have been reported to enhance the effects of the oral anticoagulant
Warfarin or its derivatives.
No comments:
Post a Comment